Pharmacist-led counseling and its effect on patient outcomes in primary care

Abstract

Background: Pharmacist-led counseling is a promising primary care intervention, yet evidence on its practical efficacy remains limited. This study appraises the effects of structured pharmacist-led counseling on medication adherence, clinical outcomes and patient satisfaction in primary care.

Methods: A six-month prospective randomized controlled trial was conducted in Mumbai, India. Patients with chronic conditions (hypertension, type 2 diabetes, dyslipidemia) were randomized into a pharmacist-led counseling group (n=120) or control group (n=120). The intervention included monthly medication review, adherence counseling, disease education, side-effect monitoring and lifestyle modification. Outcomes measured included MMAS-8 adherence scores, systolic blood pressure, HbA1c, hospital admissions, patient satisfaction and drug-related problems.

Results: At six months, the intervention group showed significant improvements. Medication adherence increased from 61.2% to 84.7% (p<0.001), systolic blood pressure decreased by 16.2 mmHg (p<0.001) and HbA1c reduced by 1.3% points (p<0.001). Hospital admissions dropped by 56.3% (p=0.002), patient satisfaction improved from 6.8 to 8.9/10 (p<0.001) and drug-related problems decreased by 60.9% (p<0.001).

Conclusion: Pharmacist-led counseling significantly improves medication adherence, chronic disease management and patient satisfaction while reducing hospitalizations and drug-related problems. Integration of pharmacist counseling into primary care is strongly recommended for sustainable, patient-centered care.